Dendritic cell‐based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model

BACKGROUND: Tumour‐specific cytotoxic T lymphocytes (CTLs) can be activated in vivo by vaccination with dendritic cells (DCs). However, clinical responses to DC‐based vaccination have only been observed in a minority of patients with solid cancer. Combination with other treatment modalities such as...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bauer, C, Bauernfeind, F, Sterzik, A, Orban, M, Schnurr, M, Lehr, H A, Endres, S, Eigler, A, Dauer, M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Group 2007
Konular:
Pancreatic Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1954993/
https://ncbi.nlm.nih.gov/pubmed/17395611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2006.108621
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller